|

Flavay™ helps
to normalize the immune system at the cellular level...
A strong immune system is the cornerstone of good health as it protects
your body against disease. There are several important ways that Flavay™
can nourish and invigorate your immune system. First, Flavay™ helps
to normalize immune functions at the cellular level. Flavay™ prevents
free radical damage to macrophages, a type of white blood cell that generates
nitric oxide to destroy bacteria, viruses and parasites. However, if nitric
oxide is overproduced it turns on its host and damages the macrophages—thereby
impairing immune function. Thus, phrases such as "double-edged sword"
are frequently applied to nitric oxide in health and disease. This emphasizes
the importance of another way that Flavay™ benefits the immune system:
regulating nitric oxide in the body. Research shows that Flavay
can help to maintain the optimal level of this free radical by helping
the body to produce adequate levelsand to neutralize nitric oxide
where it does harm.
Finally, by increasing the activity of vitamins C and E in the body,
Flavay™ helps the body maintain its antioxidant defenses, giving
the immune system more ammunition to fight infection.
How
Your Immune System Works
Although it's called a
"system," the immune system is not associated with one
particular organ but it's a collection of cells that "speak" to
one another—and with the rest of the body— through chemical messengers
(the immunotransmitters) and thereby work in close harmony to protect the
body from the harmful effects of bacteria, viruses, parasites and
environmental toxins.
Macrophages
are the immune system's foot soldiers, capable of engaging in
hand-to-hand combat as they literally gobble up invaders to
destroy them.
|
The most important components of the
immune cells are the white blood cells (lymphocytes), which include
T-cells, B-cells and macrophages. Macrophages are the immune system's foot
soldiers, capable of engaging in hand-to-hand combat as they literally
gobble up invaders to destroy them.
The white blood cells depend upon
immunotransmitters called "cytokines" to communicate with one
another and to coordinate their ferocious activity. Cytokines are to the
immune system what neurotransmitters are to the brain. Just as the brain
relies upon neurotransmitters to exchange information among its neurons
and with the rest of the body, so your immune system depends upon
cytokines.
When your body is threatened by an
invasion, cytokines signal your immune system to mobilize reserve troops
of white blood cells. When the invasion is over, your cytokines are
responsible for sending the signals to stop mobilizing the troops. In
other words, these immunotransmitters coordinate your white blood cells,
boosting their activity at times of infection, injury, or other demands
and reining them back in after battle.
Flavay™
Normalizes Immune Cell Functions and
Actually Boosts Immune Function
Flavay™
can restore cytokine imbalances and thereby normalize
white blood cell activity—normalizing immune function.
|
When the body fights off an infection,
the cytokines go to work, sending messages to the brain that cause more
white blood cells to mobilize. The more white blood cells your body
activates, the more free radicals they produce. These free radicals are
among your immune system's most powerful weapons, as a response to injury
and during times of disease, emotional stress and aging. Research
demonstrates that Flavay™ has the power to restore cytokine imbalances
and can normalize white blood cell activity, thereby normalizing immune
function.
Flavay™
Scavenges the Body's Terrorists:
Rampaging Free Radicals
Free radicals are like pellets of poison
that destroy invaders by interfering with their cellular machinery,
literally dissolving or breaking down the genetic material of bacteria,
toxins and viruses.
When all is going well, the immune system
is capable of identifying foreign invaders such as viruses and bacteria by
accurately "reading" molecular codes found on cell surfaces.
These molecular codes are like flags of different armies, and the immune
system will not attack a cells if it "reads" a flag belonging to
the body's own host army. Unfortunately, however, free radicals can
interfere with the biological components of our healthy cells, just as
they destroy invaders. This leads to many diseases.
Nitric
Oxide Toxicity and Abnormal Immune Responses
Contemporary
research shows that elevated levels of nitric oxide
appear to contribute to arthritis and other disorders associated
to abnormal immune responses.
|
Contemporary research shows that elevated
levels of nitric oxide (sometimes referred to as "NO") appear to
contribute to a number of seemingly different disorders that all have a
common element of abnormal immune or inflammatory responses.
Studies of arthritis, colitis, and other
inflammatory disorders have all demonstrated elevated levels of nitric
oxide synthesis. In the case of arthritis, nitric oxide has been
implicated in the destruction of the pericellular and extracellular matrix
of cartilage in arthritis.
Arthritis is an umbrella term for more
than 100 different conditions that produce either inflammation of
connective tissue (joints and tendons) or degeneration of the articular
cartilage, a wearing down of the protective covering that cushions the
ends of bones, allowing bones to rub together without causing damage to
the joints.
When joints become arthritic, they become
inflamed and enlarged, interfering with the normal flow of blood. For
example, when you bend an arthritic knee, you cut off blood flow to the
area which sets into motion of a chain of events that will lead to a burst
of free radicals when the blood flow returns (known as "reperfusion
injury"). When you release the knee, a proliferation of free radicals
causes the area to become even more inflamed, contributing to the
degeneration of the joint, which becomes more swollen and worn down.
High levels of nitric oxide have also
been implicated in the inflammation that is associated with asthma.
Asthmatics exhale significantly higher levels of nitric oxide and type II
nitric oxide synthase (also known as "NOS") expression is
increased in biopsy specimens from asthmatics.
It's long been recognized that nitric
oxide is essential for normal blood circulation as it controls the
muscular tone of blood vessels and regulates circulation and blood flow.
However, excessive amounts of nitric oxide can be deadly to the
cardiovascular system and actually contribute to disease and
inflammation. High levels of nitric oxide can restrict blood flow and
promote production of more free radicals, including the dangerous
peroxynitrate.
Flavay™
can help regulate a healthy balance of nitric oxide in
the body.
|
Flavay™ can significantly scavenge
nitric oxide radicals. However, as we'll discuss next, your body needs a
certain amount of nitric oxide in order to maintain good health. Nitric
oxide is paradoxical. It can both mediate normal physiological functions
and it can be highly toxic. Nitric oxide can act as an anti-inflammatory
under normal health conditions, but it can have the opposite effect and
cause more inflammation to an already inflamed area when overproduced. The
key, therefore, is to maintain the optimum balance of this
double-edged sword, nitric oxide.
When the immune system's cytokines
activate macrophages (the white blood cells capable of gobbling up
invading viruses and bacteria), the macrophages produce large amounts of
nitric oxide in the course of battle. Nitric oxide is a colorless gas
produced by many different cells in the body that, depending on the
situation, can be very good or very bad. Nitric oxide
plays several important roles in the body:
- Nitric oxide is an important
signaling molecule that turns genes on and off.
- By controlling the muscular tone of
blood vessels, nitric oxide regulates the circulation and normalizes
blood flow.
- Nitric oxide modulates communication
between brain cells and is instrumental in helping us concentrate
and learn new information, and also in maintaining memory.
- When produced by immune cells,
nitric oxide fights infection, kills tumor cells and promotes wound
healing.
- Nitric oxide is essential for
perceiving pleasure and pain, and it helps translate sexual
excitement into penile erections.
- Nitric oxide aids in digestion of
food by helping to control gastric movements.
But nitric oxide can be very destructive
under other circumstances:
- Nitric oxide restricts blood flow.
- When produced in excess by immune
cells, nitric oxide can trigger chronic inflammation, which can
cause arthritis, colitis, inflammatory bowel disease and possibly
cancer.
- Nitric oxide promotes production of
more free radicals.
- In the brain, nitric oxide can
hamper mental function and cause memory loss and brain aging.
The real trouble starts when nitric oxide
encounters the superoxide free radical and becomes peroxynitrate, which
destroys antioxidants like glutathione, vitamin E and common flavonoids,
and damages proteins in the body. The good news is that Flavay™
scavenges peroxynitrate and has a remarkable modulatory effect on nitric
oxide—helping to maintain optimal levels in the body and neutralizing
this free radical where it does harm.
"Radical
Scavenger Effect" of Flavay™
Protected by U.S. Patent No. 4,698,360
Flavay™ is the actual product—used in
the experiments—by which Dr. Jack Masquelier established and patented
the "radical scavenger effect."
|
"[A]
method for preventing and fighting the harmful biological
effects of free radicals in the organism of warm blooded
animals and more especially human beings, namely cerebral
involution, hypoxia following atherosclerosis, cardiac or cerebral
infarction, tumour promotion, inflammation,
ischaemia, alterations of the synovial liquid, collagen
degradation, among others. The method consists in
administering to said animals and especially to human beings an
amount, efficient against said effects, of a plant extract with a
proanthocyanidins content which has a radical scavenger
effect"—Dr. Jack Masquelier, U.S. Patent No.
4,698,360.
|
Flavay™ is
the product—used in the actual experiments—by which
Dr. Jack Masquelier established and patented the "Radical
Scavenger Effect."
|
Flavay's™ strong antioxidant power is
patented—as a scavenger of the free radicals that play a major
role in the initiation, duration and breakdown of inflammation. That means
that your immune system works better, your joints hurt less, and your
blood flows better, all because of Flavay™.
Flavay
Increases the Activity of Vitamins C and E
Flavay™ recycles and significantly
extends the lifetime of vitamin C and potentiates vitamin E, and thereby
creates a more powerful, synergistic antioxidant defense in the body. This
is important because vitamins C and E are key players in the body's
protective antioxidant army.
Antioxidants fight corrosive and
destructive forces that constantly work to break down our bodies.
Overwhelming scientific evidence demonstrates that those of us who eat a
diet rich in antioxidants and take antioxidant supplements will live
longer and healthier lives. Working as a defensive army, antioxidants work
together in the body to maintain our health and vigor by protecting us
from damage caused by rampaging free radicals which, like terrorists,
injure healthy cells and tissues.
Don't underestimate the threat that free
radicals pose to our health. Contemporary scientists now believe that free
radicals are causal factors in nearly every known disease, from heart
disease to arthritis to Parkinson's to Alzheimer's to ALS to multiple
sclerosis to cataracts to the aging process itself.
As
a free radical scavenger, Flavay™ is like an antioxidant prize
fighter that can successfully take on all challengers, big or
small, in any kind of weather.
|
As a free radical fighter, Flavay™
comes to the aid of the body more quickly than other antioxidants,
reducing the potential for free radical damage and the ravages of aging.
Flavay™ also possesses more reactive sites for neutralizing free
radicals than other known antioxidants. Furthermore, Flavay™ permits
reactivity with both positively and negatively charged free radical
species. What this means is that Flavay™ can “quench” or
“scavenge” (neutralize) a broad variety of free radicals. Highly
reactive as an antioxidant in both lipid (fat) and aqueous (water) phases,
Flavay™ neutralizes oxygen free radicals and is a valuable protector of
healthy cells in a variety of internal conditions. This is a unique
property among antioxidants, as most work either in lipid or aqueous
phases, but not both. As a free radical scavenger, Flavay™ is like an
antioxidant prize fighter that can successfully take on all challengers,
big or small, in any kind of weather.
Flavay™:
More Than 50 Years of Protection
Now available in the United States, Flavay™
is the actual polyphenol that has been licensed and sold in France since
1950. And, Flavay Plus™
utilizes the dynamic interplay between Flavay™ and the other antioxidant
nutrients and their co-factors in order to provide you and your family
with the best that nutritional science has to offer for immune
protection—in a convenient, cost effective capsule.
CLICK HERE FOR AN INDEPENDENT
LAB REPORT
Statements made herein have not been
evaluated by the Food and Drug Administration. These products are not intended
to diagnose, treat, cure or prevent any disease.
|
REFERENCES:
Top
|
Masquelier, J. Plant extract with
a proanthocyanidins content as a therapeutic agent having radical scavenging
effect and use thereof. U.S. Patent No. 4,698,360, 1987.
Masquelier, J. A lifetime devoted to OPC and Pycnogenols. Alfa Omega Editrice,
Pub., 1996.
Schwitters, B., Masquelier, J. OPC in practice. Alfa Omega Editrice, Publishers,
1995.
Lombard, J., Germano, C. The brain wellness plan: breakthrough medical,
nutritional and immune-boosting therapies to prevent and treat: depression,
Alzheimer's disease, chronic fatigue syndrome, attention deficit disorder,
multiple sclerosis, Parkinson's disease, Lou Gehrig's disease. Kensington
Pub. Corp., 1998.
Kilham, C., Masquelier, J. OPC: The miracle antioxidant. Keats Publishing,
Inc., 1997.
Packer, L., et al. The antioxidant miracle: your complete plan. John Wiley
& Sons, Inc., 1999.
Packer, L., et al. Antioxidant food supplements in human health. Academic
Press, 1999.
Lincoln, J., Hoyle, C.H.V., Burnstock, G., Nitric oxide in health and disease.
Cambridge University Press, 1997.
Moncada, S., Nistico, G., Bagetta, G., Higgs, E.A. Nitric oxide and the
cell. Princeton University Press, 1998.
Facino, R.M., et al. Free radical scavenging action and anti-enzyme activities
of procyanidines from vitis vinifera. A mechanism for their capillary protective
action. Arzneimittelforschung, 44: 592-601, 1994.
Passwater, R.A. The antioxidants: the nutrients that guard your body. Keats
Publishing, Inc., 1985.
Barilla, J. et al. The nutrition superbook: volume 1: the antioxidants.
Keats Publishing, Inc., 1995.
Facino RM, et al. Free radical scavenging action and anti-enzyme activities
of procyanidines from Vitis vinifera. A mechanism for their capillary protective
action. Arzneimittelforschung, 44: 592-601, 1994.
Kuttan R, et al. Collagen treated with catechin becomes resistant to the
action of mammalian collagenase. Experientia, 37: 221-223, 1981.
Masquelier, J., et al. Stabilization du collagene par les oligomeres procyanidoliques.
Acta Therapeutica, 7:101-105, 1981.
Masquelier, J. Aspects pharmacologiques nouveaux de certains flavonoides.
A Vie Medical 12:1969.
Laparra, J., et al. Etude pharmaco-cinetique des oligomers procyandoliques
totaux du raisin. Acta Therapeutica, 4, 1978.
Laparra, J., et al. Etude pharmacocinetique des oligomeres flavonoliques.
Plantes med et phyto, Tome XI, pp. 133-142, 1977.
Robert A.M.; Groult, N.; Six, C.; Robert, L. Etude de laction des
oligomeres procyanidoliques sur des cellules mesenchymateuses en culture.
Ii lattachment des fibres elastiques aux cellules. (Study of the effect
of procyanidolic oligomers on mesenchymal cells in culture. Ii attachment
of elastic fibers to the cells.) Pat Biol, (30)6:601-7, 1990.
Porter, Lawrence J., Wong Rosalind Y. Chan, Bock G. The molecular and crystal
structure of (+)-2,3-trans-3,4-trans-leucocyanidin [(2r,3s,+r)-(+)-3,3,
4.4, 5.7-Hexahydroxyflavan] dihydrate, and comparison of its
heterocyclic ring conformation in solution and the solid state. Journal
of the Chemical Society; Perkin Transactions I 1985. pp. 1413-17.
Masquelier, J. Proanthocyanidins et radicaux libres. 1985.
Uchida, S., et al. Condensed tannins scavenge active oxygen free radicals.
Med Sci Res, (15) 1987. pp. 831-832.
Ariga, T. Radical scavenging action and its mode in procyanidins b-1 and
b-3 from azuki beans to peroxyl radicals. Agric Biol Chem, 54(10) 1990.
pp. 2499-2504.
Da Silva, R., et. al. Radical scavenger capacity of different procyanidins
from grape seeds. Presented at a symposium, Free radicals in biotechnology
and medicine. Royal Society Of Chemistry, London January 1990, pp.
79-80.
Bauman, J., Wurm, G., Bruchhausen, F. Hemmung der prostagladinsynthetase
durch flavonoide und phenolderivate im vergleich nit deren 02 radikalfangereigenschaften
Arch Pharm, (Weinheim) 313 (1980) pp. 330-337.
Flesch M., et al., Effects of red and white wine on endothelium-dependent
vasorelaxation of rat aorta and human coronary arteries. Am J Physiol 1998;275:1183-94.
Fitzpatrick, D.F., Fleming R.C., Bing B, Maggi DA, O'Malley RM. Isolation
and characterization of endothelium-dependent vasorelaxing compounds from
grape seeds. J Agr & Food Chem In press.
Fitzpatrick, D.F., Maggi D, Bing B, Coffey RG. Vasorelaxation, endothelium,
and wine. BioFactors 1997;6:455-459.
Fitzpatrick, D.F., Hirschfield SL, Ricci T, Jantzen P, Coffey RG. Endothelium-dependent
vasorelaxation caused by various plant extracts. J Cardiovasc Pharmacol
1995;26:90-95.
Fitzpatrick, D.F., Hirschfield SL, Coffey RG. Endothelium-dependent vasorelaxing
activity of wine and other grape products. Amer J Physiol 1993;265:H774-H778.
Kuttan, R., Donnelly, P.V., Di Ferrante, N. Collagen treated with catechin
becomes resistant to the action of mammalian collagenase. Experientia, 37:
221-223, 1981.
Masquelier, J. Procyanidolic oligomers. J Parums Cosm Arom, 95: 89-97, 1990.
Tixier, J.M., et al. Evidence by in vivo and in vitro studies that binding
of pycnogenols to elastin affects its rate of degradation by elastases.
Biochem Pharmacol, 33: 3933-3939, 1984.
Kakegawa, H., et al. Chem. Pharm. Bull. 33:5079, 1985.
Harmand, M.F., Blanquet, P. The fate of total flavanolic oligomers extracted
from vitus vinifera l. in the rat. European Journal of Drug
Metabolism and Pharmaccokinetics. 1978, No. 1 pp. 15-30.
Delrieu, P., Ding J., Escande, B., Samain, D. Free-radical scavenging activity
of proanthocyanidolic oligomers encapsulated in glycospheres: an in vivo
and in vitro study. Cosmetology Department & S Biovectors, Ramonville
St. Agne France. pp. 1-9.
Meunier, M.T., Villie, F., et al. Inhibition of angiotensin i converting
enzyme by flavanolic compounds: in vitro and in vivo studies. Planta Medica,
May 26, 1986. pp. 12-15.
Barbier, A., et al. Activite angioprotectrice des oligomeres procyanidolques
chez lanimal-oedenme de la patte. Sanofi Res Toul Cedex Fr, pp31-40.
Barbier, A., et al. Activite angioprotectrice des oligomeres procyanidolques
chez lanimal-activite aniagoniste vis-a-vis des mediateurs de linflamation.
Sanofi Res Toul Cedex Fr, pp. 31-40.
Dubos, C., Durst, G., Hugonot, H. Evolution de la resistance capillaire,
spontanement ou artificiellement diminuee par laction dune substance
capillaro-toxique chez des personnes agees--action benefique dun agnet
actif sur la micro-circulation: lEndotelon. Inform. Therapeut. 1980.
pp. 302-305.
Dartenuc, J.Y., et al. Resistance capillaire en geriatrie etude dun
microangioprotecteur-Endotelon. Bordeaux Med. 13:903-7, 1990.
Lagrue, G., Olivier-Martin, F., Grillot, A. Etude des effets des oligomeres
du procyanidol sur las resistance capillaire dand lhypertension arterielle
et certaines nephropathies. Sen. Hosp. Paris 18-25 Septembre, 1981.
Beylot, C., Bioulac, P. Essai therapeutique dun angioprotecteur peripherique,
lEndotelon. Actualite Therapeutique Gaz. Med. de France (87)22:2919-24,
1980.
Lesbre, F.X., Tigaud, J.D. Effect de lEndotelon sur lindice
de fragilite capillaire dan une population specifique: les sujets cirrhotiques.
Gaz. Med. de France, (90)24 1983.
Sarrat, L. Abord therapeutique des troubles fonctionnels des membres inferieurs
par un microangioprotecteur lEndotelon. Bordeaux Med, 11:685-8, 1981.
Delacroix, P. Etude en double aveugle de lEndotelon dans linsuffisance
veineuse chronique. Therapeutique, la Revue de Medicine, (27-28) Sept. 1981.
pp. 1793-1802.
Thebaut, J.F, Thebaut, P., Vin, F. Etude de lEndotelon dand les manifestations
fonctionnelles de linsuffisance veineuse peripherique-resultats dune
etude en double aveugle portant sur 92 patients. Gazette Medicale,
(92)1, 1985. pp. 96-100.
Chang, W.C., Hsu, F.L. Inhibition of platelet aggregation and arachidonate
metabolism in platelets by procyanidins. Prostagland Leukotri Essent Fatty
Acids, 38:181-8, 1989.
Masquelier, J. Pycnogenols: recent advances in the therapeutical activity
of procyanidins. Supplement of Planta Medica, Journal of Medicinal Plant
Research and Journal of Natural Products, July 1980 pp. 243-256.
Henning, B., et al. Lipid peroxidation and endothelial cell injury: implications
in atherosclerosis. Free Rad Path & Med, (4)1988 pp. 99-106.
Masquelier, J. Les procyanidols du vin leur role dans lalcoolisme.
pp. 88-93.
Gazave, J.M. Notions recentes sur les capillaires unpub. bulletin
from the Laboratoire De Physiologie Patholigie pp. 26-29.
Ruf, J.C. Wine and polyphenols related to platelet aggregation and atherothrombosis.
Office International Vigne et du Vin, Nutrition and Health Unit, Paris France;
Drugs under Experimental and Clinical Research (Switz.) 25/2-3 (125-131),
1999.
Blaszo, G. Gabor, M. Oedema-inhibiting effect of procyanidin. Acta Physiologica
Academiae Scientiarum Hungaricae, Tomus 56(2):235-240, 1980.
Tayau, M.F, LeFevre, G. Action du leucocyanidol sur lhyalaluronidase.
Bull Soc Pharm Bordeaux, 95:132-136, 1956.
Lamy, M. Utilization des oligomeres procyanidoliques en gynecologie. Essai
Therapeutique Tomel (14) Sept. 2, 1981. pp. 1021-22.
Henriet, J.P Une Etude Exemplaire Pour Un Phlebotrope: letude
EIVE. Unpub., pp. 77-83.
Pfister, A., Simon, M.T., Gazave, J.M. Sites de fixation des oligomeres
procyanidoliques dans la paroi des capillaires sanguins du poumon decobaye.
Acta Therapeutica (8) 1982. pp. 223-237.
Kuttan, R., Donnelly, P., Di Ferrante, N. Collagen treated with (+)
-catechin becomes resistant to the action of mammalian collagenase.
Laboratory of Connective Tissue Research, Dept. of Biochem. Baylor Col.
of Med., Houston TX. 28, May, 1980.
Gendre, P., Laparra, J., Barraud, E. Effect protecteur des oligomeres
procyanidoliques sur le lathyrisme experimental chez le rat. Ann.
Pharm. Francaises, (43)1, 1985 pp. 61-73.
Corbe, C., Boissin, J.P., Siou, A. Light vision and chorioretinal circulation.
Study of the effect of procyanidolic oligomer (Endotelon). Jn. Fr. Opthalmol,
(11)5:453-460, 1988.
Boissin, J.P., Corbe C., Siou, A. Chorioretinal circulation and dazzling:
use of procyanidol oligomers (Endotelon). Bull Soc Ophtalmol Fr, 88(2):173-4,
177-9, 1988.
Proto, F. et al. Electrophysical study of vitis vinifera procyanoside oligomers
effects on retinal function in myopic subjects. Ann Ott Clin Ocul, 114:85-93,
1988.
Saracco, J.B., Estachy, G.M. Etude d lEndotelon en opthalmologie.
Gaz Med de France, 88:2035-2038, 1981.
Scharrer, A., Ober, M. Anthocyanosides in the treatment of retinopathies.
Klin Monatsbl Augenheilkd, 178:386-389, 1981.
Corbe, C., et al. Microangiopathy of the retina. J. Fr. Opthalmol, 11:453,
1988.
Verin, M.M., Vildy, A., Maurin, J.F., Retinopathies et O.P.C. Bordeaux Medicale,
(16)11. pp. 1467-74, 1978.
Soyeux, A. et al. Endotelon. Diabetic retinopathy and hemorheology. Bull
Soc Ophtalmol Fr. 87(12):1441-4, 1987.
Fromantin, M. Les oligomeres procyanidoliques dans le traitement de
la fragilite capillaire et de la retinopathie chez les diabetiques. A propos
de 26 cas. Med Int, 16(11):432-434, Nov. 1981.
Arne, J.L. Contribution a letude des oligomeres procyanidoliques:
Endotelon, dans la retinopathie diabetique (a propos de 30 observations).
Gaz. Med. de France, Vol. 89, No. 30, Oct. 8, 1982.
Baruch, J. Effect of Endotelon in postoperative edema. Results of a double-blind
study versus placebo in 32 female patients. Ann Chir Plast Esthet 29(4):393-5,
1984.
Rao, C.N. et al. Influence of bioflavonoids on the collagen metabolism in
rats with adjuvantinduced arthritis. Ital J Biochem. 30:54-62, 1981.
Gabor, M. Pharmacologic effects of flavonoids on blood vessels. Angiologica,
9:355-374, 1972.
Havsteen, B. Flavonoids, a class of natural products of high pharmacological
potency. Biochem Pharmacol, 32:1141-48, 1983.
Reimann, H.J., Lorenz, W., Fischer, M., Frölich, R., Meyer, H.J. Berkhauser
Verlag, Vol. 7/1, Univ. of Marburg/Lahn, Ger., 1977.
Masquelier, J. Action protectrice du vin sur lulcere gastrique. Resultats,
p. 61.
Amella, M., et al. Inhibition of mast cell histamine release by flavonoids
and bioflavonoids. Planta Medica, 5116-20, 1985.
Shaw, R. How [Australian] PycnoGenol [MASQUELIERs®] Helps Sports
People.
Masquelier, J. Procyanidolic oligomers (leucocyanidins). Parfums Cosmet
Arom 95:89-97, 1990.
Pecking, A., Desprez-Curely, J.P., Megret, G. Oligomers procyanidoliques
(Endotelon) dans le traitement des lymphoedemes post-therepeutiques de members
superieurs. Symposium Satellite, Congres International dAngiologie,
Toulouse, France, 4-7 Oct. 1989.
Fahey, T.D., Pearl M. Hormonal effects of phosphatidylserine during 2 weeks
of intense training. Abstract submitted to national meeting of the Amer
College of Sports Medicine, June 1998.
Monteleone, P., Maj, M., Beinat, L., Natale, M., Kemali, D. Blunting by
chronic phosphatidylserine administration of the stress-induced activation
of the hypothalamo-pituitary-adrenal axis in healthy men. Eur J Clin Pharm
43: 385388, 1992.
Fahey, T.D., et al. The hormonal and perceptive effects of phosphatidylserine
administration during two weeks of resistive exercise-induced overtraining.
Bio of Sport 15(3):135-44, 1998.
Laparra, J., Michaud, J. Masquelier, J. Action des oligomeres procyanidoliques
sur le cobaye carence en vitamin c. Tavaux Originaux, University of Bordeaux,
1976.
Masquelier, J. Action comparee de divers facteurs vitaminiques p sur loxydation
de lacide ascorbique par les ions cuivriques. Bull. de la Societe
de Chimie Biologique XXXIII (3-4) 1951. pp. 302-304.
Masquelier, J. Action comparee de divers facteurs vitaminiques p sur lacide
ascorbique-oxydase. Bull. de la Societe de Chimie Biologique XXXIII (3,4)
1951. pp.304-306
Kakegawa, H., Matsumoto, H., Endo, K., Satoh, T., Nonaka, G., Mishioka,
I. Inhibitory effects of tannins on hyaluronidase activation and on
the degranulation from rat mesentery mast cells. Chem. Pharm. Bull.
33(11)1985. 5079-5082.
Reiman, H.J., Lorenz, M., Fischer, R., Frolich, H., Meyer, J. Histamine
and acute haemorrhagic lesions in rat gastric mucosa: prevention of stress
ulcer formulation by (+)-catechin, an inhibitor of specific histidine decarboxylase
in vitro. Dirkhauser Verlag,Vol. 7/1, 1977.
Pariente, J.J. Parientl-Amsellem, J. Les oedemes post-traumatoqies
chez le sportif: essai controle de lEndothelon. Actualite Therapeutique
90(3) 2/11 1983 pp. 231-235.
Masquelier, J., et al. Flavonoids et Pycnogenols Int J Vit Nut
Res, (49)3:307-311, 1979.
Yu, C. L. et al. Mutagenicity of proanthocyanidins. Food Chem. Toxicol.
25(2):135-9, 1987.
Pantaleoni, G.C., Quaglino, D. Univerisity of Aquila Pharmacol-Toxicologica
Report, 1971.
Laparra, J., et al., Acta Therapeutica, 4:233, 1978.
Volkner, Wolfgang Muller, Ewald, Micronucleus assay in bone marrow cells
of the mouse with Pycnogenol. Cytotest Cell Research GmbH & Co., projects
143010 & 143021; Feb. 1989.
Acute and chronic toxicity tests. International Bio-Research, Inc., Hanover,
Germany, 1967-1971.
Dumon, M., Michaud, J., Masquelier, J. Proanthocyanidin content in vegetable
extracts to be used in the preparation of medicines. Bull. Soc. Pharm. Bordeaux,
129:51-65, 1990.
|
|